4.6 Review

Diagnosis and new treatments in genetic neuropathies

期刊

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/jnnp.2008.158295

关键词

-

资金

  1. Medical Research Council
  2. Muscular Dystrophy Campaign
  3. Department of Health's National Institute for Health Research Biomedical Research Centres
  4. NINDS
  5. Muscular Dystrophy Association
  6. Charcot-Marie-Tooth Association
  7. Medical Research Council [G0601943] Funding Source: researchfish
  8. MRC [G0601943] Funding Source: UKRI

向作者/读者索取更多资源

The genetic neuropathies are a clinically and genetically heterogeneous group of diseases of which the most common types are Charcot-Marie-Tooth disease (CMT), the hereditary sensory and autonomic neuropathies and the distal hereditary motor neuropathies. More than 30 causative genes have been described, making an accurate genetic diagnosis increasingly possible. Although no specific therapies are yet available, research into their pathogenesis has revolutionised our understanding of the peripheral nervous system and allowed the development of rational approaches to therapy. The first therapeutic trials in CMT are currently underway. This review will suggest an approach to the diagnosis of these disorders and provide an update on new therapies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据